Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA Academy of Cardiovascular and Pulmonary PT and Academy of Acute Care: Role of Physical Therapists in the Management of Individuals at Risk for or Diagnosed With Venous Thromboembolism Evidence-Based Clinical Practice Guideline 2022 (CPG+)

Aug 1, 2022/CPG

This update of a 2016 guideline provides assistance to physical therapists in the decision-making process when treating patients at risk for venous thromboembolism (VTE) or diagnosed with a lower extremity deep vein thrombosis (LE DVT).

Emergency Preparedness

The time to prepare for emergencies is long before they happen.

The Physical Therapy Outcomes Registry: 2019 by the Numbers

Dec 11, 2019/News

The Registry integrates with EHRs to help providers easily benchmark patient outcomes, participate in the MIPS, and improve patient care.

Notes From the Field: MIPS, Quality Improvement, and the Physical Therapy Outcomes Registry

Jun 9, 2019/Interview

APTA spoke with Peyton Fandel, PT, DPT, who played a key role in evaluating the potential benefits of MIPS and enrollment in APTA's registry.

Study Finds Disparities in White, Black Use of PT Services

Nov 8, 2022/Review

A review of electronic health records also found white patients received services for musculoskeletal pain faster than Black patients.

6 APTA Resources You May Have Missed in 2022

Dec 19, 2022/Roundup

From long COVID guidance to consumers' attitudes about the profession, APTA produced a range of information that helps you thrive.

2021 Lynda D. Woodruff Lecture

Jun 17, 2021/Video

Improving diversity, equity, and inclusion within the field of physical therapy has taken many challenges.

MACRA Makes Macro Changes

Sep 1, 2015/Column

As provisions of the new law take effect, PTs had best adopt quality measures and learn more about innovative care-delivery models being created in their communities.

Study: Even Small Amounts of PA Can Reduce CVD Risk Among the Elderly

Dec 4, 2017/Review

This study is notable because of its focus on participants 65 and older, and its 18-year median follow-up duration.